Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
AstraZeneca
UBS
Mallinckrodt
Baxter
Federal Trade Commission
Colorcon
Cerilliant
Deloitte

Generated: May 22, 2018

DrugPatentWatch Database Preview

Details for Patent: 8,497,256

« Back to Dashboard

Which drugs does patent 8,497,256 protect, and when does it expire?

Patent 8,497,256 protects GIAZO and is included in one NDA.

This patent has nine patent family members in eight countries.
Summary for Patent: 8,497,256
Title:Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives for the treatment of males
Abstract: The instant application provides methods and compositions for the treatment of male subjects having ulcerative colitis.
Inventor(s): Forbes; William (Raleigh, NC), Bortey; Enoch (Chapel Hill, NC), Johnson; Lorin (Palo Alto, CA)
Assignee: Salix Pharmaceuticals, Ltd (Raleigh, NC)
Application Number:13/094,261
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 8,497,256
Patent Claim Types:
see list of patent claims
Use; Formulation; Dosage form;

Drugs Protected by US Patent 8,497,256

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Valeant Pharms Intl GIAZO balsalazide disodium TABLET;ORAL 022205-001 Feb 3, 2012 AB RX Yes Yes ➤ Sign Up ➤ Sign Up TREATMENT OF MILDLY TO MODERATELY ACTIVE ULCERATIVE COLITIS IN MALE PATIENTS ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
Mallinckrodt
US Department of Justice
McKinsey
Chubb
Teva
Boehringer Ingelheim
Merck
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.